Product Information
NORA-BE TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0943 per EA under NDC 52544062928. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Norethindrone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.35 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
52544062928
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
NORETHINDRONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017060FDA Approved
Before 1982
TE Code
AB1
On Market Since
5/12/2005
Pharmacological Classes
Price Statistics
The NADAC for NORA-BE TABLET has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 85.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0943 per EA |
|---|---|
| All-time high | $0.6358 (Dec 10, 2014) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.2122 |
| Average price | $0.2648 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-0.1%
6M
+1.1%
1Y
+6.2%
3Y
-29.2%
5Y
-47.4%
All
-85.0%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NORA-BE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORA-BE TABLET, manufactured by Actavis Pharma, Inc., is $0.0943 per EA (NDC 52544062928), effective Jul 1, 2026.
How has the price of NORA-BE TABLET changed over time?
Over the history we have for it, the NADAC for NORA-BE TABLET has declined 85.0%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORA-BE TABLET?
Since Nov 28, 2013, the NADAC for NORA-BE TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.6358 (Dec 10, 2014), with a median of $0.2122 per EA.
Are there cheaper alternatives to NORA-BE TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HEATHER 0.35 MG TABLET, is $0.0906 per EA — about 4% below NORA-BE TABLET.
Who manufactures NORA-BE TABLET?
NORA-BE TABLET (NDC 52544062928) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.